Full Text View
Tabular View
No Study Results Posted
Related Studies
Open Label Study of Alefacept Injections to Patients With Moderate to Severe Psoriasis
This study is currently recruiting participants.
Study NCT00678470   Information provided by University of California, San Francisco
First Received: May 13, 2008   Last Updated: November 20, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Moderate to Severe Psoriasis
Additional conditions recognized in this trial
Psoriasis
More general conditions related to this trial
Skin Diseases
Skin Diseases, Papulosquamous
Interventions listed in this trial
Intralesional Alefacept
Additional drug interventions recognized in this trial
Alefacept
More general drug interventions related to this trial
Dermatologic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University of California, San Francisco


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services